Mynd... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MYND advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 25, 2025. You may want to consider a long position or call options on MYND as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MYND just turned positive on April 21, 2025. Looking at past instances where MYND's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for MYND moved out of overbought territory on May 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where MYND's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
MYND moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MYND broke above its upper Bollinger Band on May 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MYND entered a downward trend on April 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.661) is normal, around the industry mean (13.559). P/E Ratio (9.123) is within average values for comparable stocks, (77.256). MYND's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.764). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.497) is also within normal values, averaging (11.727).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MYND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
a provider of objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD)
Industry MiscellaneousCommercialServices
A.I.dvisor indicates that over the last year, MYND has been loosely correlated with BAER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MYND jumps, then BAER could also see price increases.
Ticker / NAME | Correlation To MYND | 1D Price Change % | ||
---|---|---|---|---|
MYND | 100% | -2.56% | ||
BAER - MYND | 48% Loosely correlated | +7.89% | ||
AERT - MYND | 36% Loosely correlated | +6.37% | ||
SKIL - MYND | 24% Poorly correlated | -2.18% | ||
ABM - MYND | 23% Poorly correlated | +1.13% | ||
CRAI - MYND | 21% Poorly correlated | +1.25% | ||
More |